Invokana Injury Prompts Patient to File Lawsuit

Home » Drug Injury » Invokana Injury Prompts Patient to File Lawsuit

An Invokana injury lawsuit accuses Janssen Pharmaceuticals of failing to warn the medical community and patients about the risk of severe Invokana side effects.

Invokana is an SLGT-2 inhibitor that is typically ingested by patients to treat type 2 diabetes. Those patients who ingested the drug and sustained an Invokana injury may find this out in the form of a stroke, severe kidney damage, respiratory failure, heart attack, diabetic ketoacidosis, or even death.

As the Invokana injury lawsuit states, the drug manufacturing company is accused of failing to warn about the serious complications putting patients directly in harm’s way.

The plaintiffs in this lawsuit allege ketoacidosis and kidney failure and say that the unreasonably dangerous drug will continue to cause injuries and damages to patients in the future.

California resident William B. says he was prescribed the medication shortly before December 2015. The Invokana injury lawsuit states that William suffered personal, economic and physical injuries as a result of taking the medication.

Other plaintiffs in this Invokana injury lawsuit include residents of South Carolina and Nebraska. All of the plaintiffs in the lawsuit say that they were never told about the risks before beginning to take the medication and were therefore put in harm’s way directly. The drugs used to treat type 2 diabetes include Invokamet and Invokana.

Invokana was the first SGLT-2 inhibitor that was approved by the FDA for use. The purpose of an SGLT-2 inhibitor is to inhibit reabsorption of glucose to lower the patient’s blood glucose. Since excess glucose is not metabolized for the patient but is instead excreted through the kidneys, plaintiffs in the Invokana injury lawsuit argue that they should have been warned about the risk of significant kidney damage or diabetic ketoacidosis.

opioidThe Invokana injury lawsuit said that the defendants were aware of the risks and failed to include it in their marketing materials.

An adverse event database indicates that those patients taking SLGT-2 inhibitors are several times more likely to report significant side effects including diabetic ketoacidosis.

The sudden onset condition can lead to organ failure and even death if it is not caught quickly.

Many of the patients who have had to file a lawsuit say that the manufacturer either knew about or should have known about the side effects and in not telling patients made those patients face a high risk of serious injuries and damage.

An Invokana injury lawsuit may include multiple claims of severe damage and pain affecting patients.

The Invokana Injury Lawsuit is Case No. 3:17-cv-02517-BRM-LHG, in the U.S. District Court for the District of New Jersey.

If you or someone you know has suffered an Invokana injury, consult with the experienced attorneys at McDonald Worley today to learn more about your rights and to figure out if you have grounds to file a lawsuit.

Disclaimer: McDonald Worley is not representing the plaintiff in this lawsuit.